Journal Club E27: Carvedilol vs propranolol: preventing decompensation in cirrhosis

from AZense Journal Club · host Azense Medical Education

Two large 2025 studies push carvedilol to the front of the formulary for portal hypertension. Here is what the evidence says, where the guidelines stand, and how to translate this at discharge.

Episode metadata supplied by the publisher feed · Published Oct 6, 2025

Embed this episode

Attribution link and audio player

Ready to play

Journal Club E27: Carvedilol vs propranolol: preventing decompensation in cirrhosis

0:00 7:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AZense Journal Club?

This episode is 7 minutes long.

When was this AZense Journal Club episode published?

This episode was published on October 6, 2025.

Can I download this AZense Journal Club episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!